人工智能(AI)在医学与健康领域被广泛视为具有巨大潜力,将可能从根本上改变医疗方式和决策模式。尽管诸如基于规则的专家系统、机器学习和自然语言模型等技术已在临床实践中有所应用,但广泛部署医疗AI仍面临诸多技术难题和伦理挑战。当前,AI在临床医学领域的应用处于早期阶段,尚未对临床诊疗产生重大影响,但随着医学领域AI的迅猛发展,这个“机会窗口”正在逐渐关闭。本文旨在探讨AI在临床实践中的应用进展和新兴潜力,重点分析其应用所面临的伦理挑战,包括数据隐私安全与偏倚、数字鸿沟与健康不公平、可解释AI与自主决策,以及错误风险与责任转移问题,并提出相应对策,以期为我国医学AI相关政策的制定提供理论依据和决策支持。
Artificial intelligence (AI) is widely seen as having great potential in the field of medicine and health, with the possibility to fundamentally transform medical care and clinical decision-making. Despite technologies such as rule-based expert systems, machine learning, and natural language models being applied in clinical practice, the widespread deployment of AI in healthcare still faces numerous technical challenges and ethical debates. Still, in its early stage of development, it has not had a significant impact on clinical diagnostics and treatment. However, with the rapid progression of AI in medicine, this"window of opportunity"is gradually closing. This study aims to explore the application progress and emerging potential of AI in clinical practice; analyze the ethical challenges, including data privacy and bias, digital divide and health inequities, explainable AI and autonomous decision-making and the incorrect risk and responsibility shift; put forward corresponding countermeasures; to provide theoretical groundwork and evidence for the policy-making related to medical AI in China.
于兰亦,翟晓梅. 人工智能在临床实践中的创新应用和伦理挑战[J]. 数字医学与健康,2024,02(02):108-112.
DOI:10.3760/cma.j.cn101909-20231127-00073版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章,不得使用本刊的版式设计。
除非特别声明,本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。